Thus, although most of the studies reviewed in this section support the interest of SIRT2 inhibition in different neurodegenerative diseases, further investigations are needed to fully understand the underlying mechanisms and signaling pathways involved before the translation of these results to human patients. This evidence concerns the gene SIRT2 and neurodegenerative disease.